Protalix BioTherapeutics
PLX
#8927
Rank
A$0.23 B
Marketcap
A$2.91
Share price
4.06%
Change (1 day)
20.91%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): A$11.65 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$61.84 Million. In 2024 the company made an earning of A$7.39 Million a decrease over its 2023 earnings that were of A$16.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$11.65 M57.55%
2024 A$7.39 M-55.62%
2023 A$16.67 M-199.05%
2022 -A$16.84 Million-40.38%
2021 -A$28.24 Million-732.31%
2020 A$4.46 M-130.53%
2019 -A$14.63 Million189.85%
2018 -A$5.05 Million-95.29%
2017 -A$0.11 Billion308.12%
2016 -A$26.26 Million-32.37%
2015 -A$38.83 Million10.11%
2014 -A$35.27 Million-7.59%
2013 -A$38.16 Million
2011 -A$44.19 Million-19.39%
2010 -A$54.82 Million20.87%
2009 -A$45.35 Million32.26%
2008 -A$34.29 Million-5.46%
2007 -A$36.27 Million
2004 -A$0.24 Million12.35%
2003 -A$0.21 Million-11.1%
2002 -A$0.24 Million-57.03%
2001 -A$0.55 Million1.03%
2000 -A$0.55 Million-53.22%
1999 -A$1.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.02 B 141,889.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.13 B 10,609.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.27 M-97.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$3.22 B 30,346.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel